key: cord-0259654-x83kgw7q authors: Roberts, A. L.; Morea, A.; Amar, A.; Zito, A.; El-Sayed Moustafa, J. S.; Tomlinson, M.; Bowyer, R.; Zhang, X.; Christiansen, C.; Costeira, R.; Steves, C. J.; Mangino, M.; Bell, J. T.; Wong, C. C. Y.; Vyse, T.; Small, K. S. title: Age acquired skewed X Chromosome Inactivation is associated with adverse health outcomes in humans date: 2022-04-05 journal: nan DOI: 10.1101/2022.04.04.22272893 sha: aa5b23321c8d23431a2d096c0e69425e30583e22 doc_id: 259654 cord_uid: x83kgw7q Background Ageing is a heterogenous process characterised by cellular and molecular hallmarks, including changes to haematopoietic stem cells, and is a primary risk factor for chronic diseases. X chromosome inactivation (XCI) randomly transcriptionally silences either the maternal or paternal X in each cell of XX,46 females to balance the gene expression with XY,46 males. Age acquired XCI-skew describes the preferential inactivation of one X chromosome across a tissue, which is particularly prevalent in blood tissues of ageing females and yet its clinical consequences are unknown. Methods We assayed XCI in 1,575 females from the TwinsUK population cohort and employed prospective, cross-sectional, and intra-twin designs to characterise the relationship of XCI-skew with molecular, cellular, and organismal measures of ageing, and cardiovascular disease risk and cancer diagnosis. Results We demonstrate that XCI-skew is independent of traditional markers of biological ageing and is associated with a haematopoietic bias towards the myeloid lineage. Using an atherosclerotic cardiovascular disease risk score, which captures traditional risk factors, XCI-skew is associated with an increased cardiovascular disease risk both cross-sectionally and within XCI-skew discordant twin pairs. In a prospective 10-year follow-up study, XCI-skew is predictive of future cancer incidence. Conclusions Our study demonstrates that age acquired XCI-skew captures changes to the haematopoietic stem cell population and has clinical potential as a unique biomarker of chronic disease risk. Ageing is a heterogenous process characterised by cellular and molecular hallmarks and can 42 manifest clinically as frailty and multimorbidity (Clegg et al., 2013; López-Otín et al., 2013) . 43 Ageing is a primary risk factor for diseases such as cardiovascular disease and cancer, and a 44 better understanding of the biomarkers of ageing promises to reduce the burden of chronic 45 disease which significantly impacts the human healthspan(López-Otín et al., 2013). 46 47 X chromosome inactivation (XCI) evolved in placental mammals to compensate for the 48 differences in size between the X and Y sex chromosomes. XCI transcriptionally silences either 49 the maternal or paternal X in each cell to equalise the gene expression between XX,46 females 50 and XY,46 males (Lyon, 1961) . The selection of which X is silenced is a random process that 51 occurs during development, with the XCI status then clonally inherited by all daughter cells. 52 Therefore, mammalian female tissues are mosaics with respect to XCI status, with an expected 53 ratio of 1:1. However, non-random patterns of XCI are observed, particularly in ageing 54 individuals with up to 40% of females over 60 years old presenting preferential silencing across 55 a tissue (Busque et al., 1996; Gale et al., 1997) . This is termed age acquired XCI-skew and is 56 highly prevalent in mitotically active blood tissue (Zito et al., 2019) . XCI-skew has previously 57 been linked to autoimmunity, which presents with a stark sex-imbalance (Chabchoub et al., 58 2009), as well as breast and ovarian cancers, albeit with inconsistent findings (Kristiansen et The stability of XCI-skew in blood has been demonstrated over 18-24 months and is thought 62 to be a gradual process affecting the whole haematopoietic stem cell population rather than 63 representing fluctuations in the active stem cell pool (Tonon et al., 1998; van Dijk et al., 2002) . 64 Therefore, though XCI-skew is a sex-specific measurable phenotype, it is a potential marker 65 of stem cell depletion or polyclonal clonal expansion of haematopoietic stem cells, which are 66 age-associated traits irrespective of chromosomal sex (Busque et al., 1996 (Busque et al., , 2012 Gale et al., 67 1997) . Clonal expansion of haematopoietic stem cells is also measurable by somatic mutations 68 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. ; https://doi.org/10.1101/2022.04.04.22272893 doi: medRxiv preprint shared across blood cells, indicating a common stem cell precursor (Xie et al., 2014) . Clonal 69 haematopoiesis of indeterminate potential (CHIP) is a cellular phenotype describing a pre-70 malignant state in which 4% of blood cells harbour the same somatic mutation (Jaiswal & 71 Ebert, 2019), thus representing monoclonal expansion, and CHIP is robustly associated with 72 all-cause mortality (Jaiswal et al., 2014) , haematological cancers (Genovese et al., 2014) , and 73 cardiovascular disease (Jaiswal et al., 2017) . 74 75 Given XCI-skew is potentially tagging changes to the haematopoietic stem cell pool, we 76 hypothesised that XCI-skew may be a marker of biological ageing and a risk factor for chronic 77 disease. We tested this hypothesis by assaying XCI-skew in 1, 575 and extreme XCI-skew equated to 91% XCI. We date-matched the XCI data with existing 89 phenotypes from TwinsUK (e.g., blood count data, molecular markers) in the subsets of 90 individuals on whom each phenotype was available (Supplementary Fig. 1) . 91 We assessed changes in frequency of XCI-skew across increasing age and identified 12% (9 of 93 75) of individuals under 40 years old (yrs) displaying XCI-skew (75% XCI), 28% (183 of 94 652) of 40-59yrs; 37% (185 of 498) of 60-69yrs; and 44% (132 of 303) of those over 70yrs 95 (Fig. 1A) . Proportions of individuals displaying extreme XCI-skew (91% XCI) remains 96 consistent at ~3-4% below the age of 60 but increases to 7% of 60-69yrs and 9% of those over 97 70yrs. These results suggest a stepwise increase in prevalence of XCI-skew happening after 40 98 years of age, then again after 60 years of age, where we also see the first increase in prevalence 99 of extreme XCI-skew (Fig. 1A) . After controlling for relatedness and zygosity, we find a 100 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 5, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Given the robust association with chronological age, we sought to establish whether XCI-skew 132 was associated with biological ageing using measures taken within one year of XCI DNA 133 sample ( Table 1) . We observed no association with smoking status (P=0.94, N=1,552) nor 134 obesity (P=0.88, N=891). We also found no association with LTL shortening (P=0.9, N = 390) 135 nor DNAm GrimAge acceleration (P=0.22, N=137). Finally, we see no association with a 136 robust frailty index (P=0.59, N=611). Together, these data, ranging from the molecular to 137 organismal level, suggest age acquired XCI-skew is independent of many known markers of 138 biological ageing and is potentially a unique biomarker with unexplored utility. 139 140 tested for associations between XCI-skew and whole blood count data, including white cell 150 differentials, in a subset of individuals with matched data (N=611, median age = 63). XCI-151 skew is association with increased monocyte abundance after multiple testing correction 152 (P=0.0038), and we observed nominal increases in abundance across other myeloid cells (Fig. 153 1B). We next tested the hypothesis that XCI-skew was associated with a myeloid lineage bias 154 using the Monocyte-to-Lymphocyte Ratio (MLR)(Chen et al., 2019) and Neutrophil-to-155 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. Table S1 ). However, we observe a strong negative association with IL-10 165 (P=0.0008, N=27; Supplementary Table S1) To ensure the observed association wasn't spuriously driven by the age component of the 187 ASCVD risk score (see Methods), we took age matched MZ and DZ twin pairs (npairs=34) 188 discordant for their XCI-skew status and tested intra-twin ASCVD risk scores. The intra-twin 189 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We also present an association with increased atherosclerotic cardiovascular disease risk score, 260 which captures traditional risk factors and estimates the risk of developing CVD in the next 10 261 years (Goff et al., 2014) . We were also able to utilise the powerful discordant twin design to 262 validate this finding, thus excluding the possibility that the cross-sectional association was 263 driven by the age component of the ASCVD risk score. Ascertaining whether XCI-skew is 264 associated with incident CVD warrants further study. 265 266 On a cellular level, we observe that increased abundance of monocytes correlates with 267 increased XCI-skew, which is of particular interest given that monocytes/macrophages are 268 involved in the inflammatory pathophysiology of CVD (Libby et al., 2016) . It is important to 269 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. with lower levels of XCI-skew, which affects >37% of females over 60, are still at elevated 288 risk of ASCVD and future cancer diagnosis. To avoid Type I error inflation, we did not run 289 additional tests to compare the extreme XCI-skew group with the random XCI group. 290 There are some limitations to our study. Despite the high sample size of individuals with 291 measured XCI, analyses are carried out in subsets of these individuals where date-matched 292 phenotype data were available. In particular, the cytokine analyses have a low sample size and 293 though we detect significant associations with IL-10, we may be underpowered to rule out the 294 possibility of detecting a weaker association with other cytokines, and this also restricted our 295 ability to control for cell type composition. Also, with only 41 deaths across the cohort, our all-296 cause mortality analysis is underpowered. A higher-powered study able to focus on specific 297 causes of mortality is warranted. Sample sizes also limited the possibilities of running analyses 298 on specific mortalities or cancer types, and these future studies are warranted. 299 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. ; https://doi.org/10.1101/2022.04.04.22272893 doi: medRxiv preprint In summary, we demonstrate XCI-skew is a highly prevalent cellular phenotype in females and 300 is associated with elevated cardiovascular disease risk and predictive of future cancer 301 incidence. Further investigations are needed to translate the biological value of XCI-skew into 302 clinical applications for studying the association of age-related haematopoietic changes and 303 chronic disease associations, regardless of chromosomal sex. Understanding the mechanisms 304 underlying this phenomenon, whether XCI-skew is reflective of other ageing markers that 305 increase disease risk, and whether it is therapeutically actionable, are areas of particular 306 interest. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. ; https://doi.org/10.1101/2022.04.04.22272893 doi: medRxiv preprint products were diluted 1:15 with nuclease-free ddH2O and pooled together with the GeneScan 333 500 LIZ size standard and analysed on an ABI 3730xl. Twin pairs were assayed on the same 334 plate and plates contained a mix of both MZ and DZ pairs. Two replicates were included on 335 each plate and a within-plate correlation of 0.99 was measured. The assay failed in 194 samples, 336 and 601 samples were homozygous for the CAG repeat and were therefore uninformative 337 (Supplementary Fig. 1) . were excluded from downstream analysis (n=12; Supplementary Fig. 1) . A mean XCI 350 percentage (0-100%) was calculated, where 50% is perfectly balanced XCI. The XCI 351 percentage data were normalised, and absolute values of the normalised distribution were taken 352 (XCI score) because the directionality of XCI away from 50% is uninformative (e.g., both 0% 353 and 100% are considered equal). 354 The categorical XCI-skew variable was created from the normalised distribution as follows: 357 standard deviation (s.d.) <1 from the mean = random XCI (0); 1< s.d. <2 = skewed XCI (1); 358 and s.d.>2 = extreme skew (2). As such, XCI-skew equated to 75% XCI, and extreme XCI-359 skew equated to 91% XCI. These thresholds are very similar to previous studies (Busque et 360 al., 1996; Gale et al., 1997) , and allowed for linear associations to be tested using the XCI-361 skew categorical variable. 362 363 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. In all regression models, a linear mixed effects model was used with relatedness and family 365 structure fitted with a random intercept using the lme4 package (Bates et al., 2015) . The relevant 366 fixed effects are described in each section below and were specific to each test. All analyses 367 were carried out using R version 4.1.1 and all plots were generated using ggplot (Wickham H, 368 2016 (Christiansen et al., 2021) . The associations were 377 tested with XCI score as the dependent variable and obesity (obese/not obese) or smoking 378 (ever/never smoker) as the independent variable, controlling for age as a fixed effect. A Frailty 379 Index (Searle et al., 2008) was calculated based on longitudinal questionnaire data and used as 380 the dependent variable, with XCI-skew as the independent variable and age and BMI as fixed 381 effects. Leukocyte Telomere Length was measured using qPCR as previously described (Codd 382 et al., 2010) , and the normalised measures were used as the dependent variable and XCI-skew 383 as the independent variable, with age and smoking as fixed effects. DNA methylation (DNAm) 384 GrimAge was calculated using 450K methylation data and GrimAge epigenetic age 385 acceleration measures were obtained from regressing epigenetic age on chronological 386 age (Costeira et al., 2021) . GrimAge Acceleration was used as the dependent variable and XCI-387 skew as the independent variable, with no additional covariates included in the model. 388 389 Whole blood count data 390 Automated whole blood count data were date-matched to the XCI DNA sample and each of 391 the 10 blood count variables were normalised. The significance threshold after Bonferroni 392 correction was P<0.005 to account for multiple testing across the 10 tests. In addition, 393 Monocyte-to-Lymphocyte Ratio (MLR) and Neutrophil-to-Lymphocyte Ratio (NLR) were 394 calculated by dividing the total monocyte or neutrophil count, respectively, by total lymphocyte 395 count. Associations were tested with XCI-skew as an independent variable after controlling for 396 age, BMI, seasonality, and smoking status as fixed effects in a linear mixed effects model. 397 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 5, 2022. ; https://doi.org/10.1101/2022.04.04.22272893 doi: medRxiv preprint Serum IL-1β, IL-10, IL-6, and TNF-α were measured simultaneously using the bead-based 400 high sensitivity human cytokine kit (HSCYTO-60SK, Linco-Millipore) according to the The ASCVD risk score was calculated for a subset of 231 individuals with date-matched data 411 on age, total cholesterol, HDL cholesterol, smoking, diabetes, systolic blood pressure, and 412 hypertension medication, as previously described (Goff et al., 2014) . A linear mixed model was 413 used to control for BMI and monocyte abundance as fixed effects (Madjid et al., 2004) . Twin 414 pairs discordant for XCI-skew but matched for date of visit and age (n=34 pairs) were used for 415 the intra-twin study, and ASCVD risk scores were compared using a one-sided paired samples 416 Wilcoxon test. 417 418 Cancer and all-cause mortality 419 Anonymised data were obtained from the National Disease Registration Service. Study entry 420 was the date of DNA sampling and follow-up occurred through to January 2020. For the cancer 421 analysis, individuals who had not experienced the event were censored at 10 years, study end 422 date, or date-of-death. All participants with a history of cancer before sampling, or within 6 423 months of sampling, were excluded from analyses, and reports of non-melanoma skin cancer 424 were filtered, leaving a sample size of 1,417. For all-cause mortality, individuals who had not 425 experienced the event were censored at 10 years or study end date. For both analyses, age and 426 family structure and zygosity were controlled for in the Cox regression model using R package 427 Survival (Therneau T, 2021) . Proportional hazards assumptions were assessed using the 428 cox.zph function of the Survival package. Kaplan-Meier plots were used for graphical 429 representation of years until diagnosis. XCI-skew and extreme XCI-skew groups were 430 combined due to the limited number of events. 431 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 5, 2022. (TR130505).This work uses data that has been provided by patients and collected by the NHS 467 as part of their care and support. The data are collated, maintained and quality assured by the 468 National Disease Registration Service, which is part of NHS Digital. 469 Neutrophil/lymphocyte ratio is 473 related to the severity of coronary artery disease and clinical outcome in patients 474 undergoing angiography Models Using lme4 Telomeres and telomerase: the 480 path from maize, Tetrahymena and yeast to human cancer and aging Association 483 Between Nonrandom X-Chromosome Inactivation and BRCA1 Mutation in Germline 484 DNA of Patients With Ovarian Cancer Nonrandom X-Inactivation Patterns in Normal Females: Lyonization 488 Ratios Vary With Age Recurrent somatic TET2 mutations in normal elderly individuals 493 with clonal hematopoiesis Analysis of skewed X-chromosome inactivation 497 in females with rheumatoid arthritis and autoimmune thyroid diseases Monocyte/lymphocyte ratio 500 is related to the severity of coronary artery disease and clinical outcome in patients with 501 non-ST-elevation myocardial infarction Novel DNA methylation signatures of 507 tobacco smoking with trans-ethnic effects Frailty in elderly 510 people Common variants near TERC are associated with mean 516 telomere length Estrogen and 520 COVID-19 symptoms: Associations in women from the COVID Symptom Study Methylation of Hpall and Hhal Sites Near the Polymorphic CAG Repeat in 524 the Human Androgen-Receptor Gene Correlates with X Chromosome Inactivation. Am. 525 Acquired skewing of X-527 chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic 528 clonal loss with age Clonal Hematopoiesis and Blood-Cancer 533 Risk Inferred from Blood DNA Sequence Issue 25 SUPPL. 1). Lippincott Williams and Wilkins The effect of frailty on survival in patients with COVID-19 (COPE): a 546 multicentre, European, observational cohort study Clonal hematopoiesis in human aging and disease Age-Related Clonal Hematopoiesis Associated with Adverse 555 Outcomes Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease White Blood Cell Count and Total and Cause-Specific Mortality in 564 the Women's Health Initiative High incidence of skewed X chromosome inactivation in young 568 patients with familial non-BRCA1/BRCA2 breast cancer High frequency of skewed X inactivation in young breast cancer patients Frailty syndrome: an overview. Clinical Interventions 574 in Aging THE PRESENT AND FUTURE 576 STATE-OF-THE-ART REVIEW Leukocytes Link Local and Systemic Inflammation Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation 582 and Highlight Pathways that Link Inflammation and Complex Disorders The 586 hallmarks of aging Chenevix-589 Trench Skewed X chromosome inactivation and breast and ovarian cancer status: 592 Evidence for X-linked modifiers of BRCA1 DNA methylation GrimAge strongly predicts lifespan and healthspan Gene Action in the X-chromosome of the Mouse Leukocyte count and 600 coronary heart disease: Implications for risk assessment X chromosome inactivation pattern in BRCA gene mutation 606 carriers Skewed X inactivation and survival: A 13-year follow-up study 610 of elderly twins and singletons Human bone marrow hematopoietic stem cells are 614 increased in frequency and myeloid-biased with age Red blood 618 cell distribution width and the risk of death in middle-aged and older adults. Archives of 619 Internal Medicine Inflammaging: disturbed interplay 621 between autophagy and inflammasomes The regulation of IL-10 production by immune cells A standard 627 procedure for creating a frailty index Peripheral blood CD14high CD16+ monocytes are main producers of 631 IL-10 Skewed X chromosome 635 inactivation and early-onset breast cancer Obesity and ageing: Two sides of the same 638 coin A Package for Survival Analysis in R Unbalanced X-chromosome 644 inactivation in haemopoietic cells from normal women Acquired skewing of Lyonization remains stable for a prolonged 648 period in healthy blood donors Adult Twin Registry Update ggplot2: Elegant Graphics for Data Analysis Age-related mutations associated with clonal hematopoietic expansion 661 and malignancies Heritability of skewed X-inactivation in female 665 twins is tissue-specific and associated with age The authors acknowledge use of the research computing facility at King's College London, 462Rosalind (https://rosalind.kcl.ac.uk), which is delivered in partnership with the National 463